Pelvic Inflammatory Disease: Metaanalysis of Antimicrobial Regimen Efficacy

Journal of Infectious Diseases

Volumn 168, Issue 4, 1993, Pages 969-978

  Washington, A Eugene ^a,b,c   Walker, Cheryl K ^a,b,c   Kahn, James G ^a,b,c   Peterson, Herbert B ^a,b,c   Sweet, Richard L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PIPERACILLIN; PROBENECID; SULBACTAM; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; DRUG COST; DRUG EFFICACY; FEMALE; GENITAL TRACT INFECTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIBIOTICS; ANTIBIOTICS, COMBINED; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HUMAN; PELVIC INFLAMMATORY DISEASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027328970     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/168.4.969     Document Type: Article

References (55)

1. Rolfs RT, Galaid EI, Zaidi AA, Pelvic inflammatory disease: trends in hospitalizations and office visits, 1979 through 1988, Am J Obstet Gynecol 1992; 166: 983-90.
2. Washington AE, Katz P, Cost ofand payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000, JAMA 1991; 266: 2565-9.
3. Peterson HR, Walker CK, Kahn JG, Eschenbach DA, Washington AE, Pelvic inflammatory disease: key treatment and management issues and options, JAMA 1991; 266: 2605-11.
4. Sweet RL, Gibbs RS, Pelvic inflammatory disease, In: Infectious diseases of the female genital tract, 2nd ed, Baltimore: Williams & Wilkins, 1990: 241-66.
5. Westrom L, Mardh PA, Acute pelvic inflammatory disease, In: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, eds, Sexually transmitted diseases, 2nd ed, San Francisco: McGraw-HilL 1990: 593-613.
6. Andersson PO, Hackl H, Jensen P, Larsen KR, A comparison of two different dosages of pivampicillin and doxycycline in patients with gynaecological infections, Curr Med Res Opin 1980; 6: 513-7.
7. Kvile G, Langeland P, Norling B, Treatment of salpingitis with pivampicillin, A comparison of twice-daily and thrice-daily dosages, Infection 1980; 8: 32-6.
8. Kunz J, Macciocchi A, Acute salpingitis and thiamphenicol: a microbiologic and therapeutic study, Sex Transm Dis 1984; II: 449-53.
9. Vige PM, Henrion RM, Thiamphenicol for treatment ofsalpingitis, Sex Transm Dis 1984; 11: 441-3.
10. Sweet RL, Ledger WJ, Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections, Obstet Gynecol 1979; 54: 193-8.
11. Monif GR, Welkos SL, Baer H, Clinical response ofpatients with gonococcal endocervicitis and endometritis-salpingitis-peritonitis to doxycycline, Am J Obstet Gynecol 1977; 129: 614-22.
12. Ledger WJ, Moore DE, Lowensohn RI, Gee CL, A fever index evaluation of chloramphenicol or clindamycin in patients with serious pelvic infections, Obstet Gynecol 1977; 50: 523-30.
13. Jenicek M, Meta-analysis in medicine: where are we and where do we want to go? J Clin Epidemiol 1989; 42: 35-44.
14. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL, Diagnosing pelvic inflammatory disease: a comprehensive analysis andconsiderations for developing a new model, JAMA 1991; 266: 2594-604.
15. Hager WD, Eschenbach DA, Spence MR, Sweet RL, Criteria for diagnosis and grading of salpingitis, Obstet Gynecol 1983; 61: 113-4.
16. Centers for Disease Control, Pelvic inflammatory disease: guidelines for prevention and management, MMWR 1991; 40(RR-5): 1-25.
17. Centers for Disease Control, 1989 STD treatment guidelines, MMWR 1989; 38(suppl): 31-4.
18. Blyth CR, Approximate binomial confidence limits, J Am Stat Assoc 1986; 81: 843-55.
19. Gilman AG, Goodman LS, Rail TW, Murad F, The pharmacological basis of therapeutics, 7th ed, New York: Macmillan, 1985.
20. Sanford JP, Guide to antimicrobial therapy 1990, Bethesda, MD: Antimicrobial Therapy, 1991.
21. Wasserheit IN, Bell TA, Kiviat NB, Microbial causes of proven pelvic inflammatory disease and efficacy of Clindamycin and tobramycin, Ann Intern Med 1986; 104: 187-93.
22. Wolner-Hanssen, Paavonen J, Kiviat N, Young M, Eschenbach DA, Holmes KK, Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline, Obstet Gynecol 1988; 71: 595.
23. Larsen JW Jr, Voise CT, Grossman JH, Comparison ofcefoxitin and Clindamycin-gentamicin for pelvic infections, Clin Ther 1987; 9: 7783.
24. Hemsell DL, Nobles BJ, Heard MC, Hemsell PG, Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease, Microbial susceptibility and clinical response to four therapeutic regimens, J Reprod Med 1988; 33: 799-805.
25. Walters MD, Gibbs RS, A randomized comparison ofgentamicin-Clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease, Obstet Gynecol 1990; 75: 867-72.
26. Walker CK, Landers DV, Ohm-Smith MJ, Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salpingitis, Sex Transm Dis 1991; 18: 119-23.
27. Apuzzio JJ, Stankiewicz R, Jain S, Kaminski Z, Lauria D, Comparison of parenteral ciprofloxacin with Clindamycin-gentamicin in the treatment of pelvic infection, Am J Med 1989; 87(suppl 5A): 148-51S.
28. Wendel GO, Cox SM, Bawdon RE, Theriot SK, Heard MC, Nobles BJ, A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis, Am J Obstet Gynecol 1991; 164: 1390-6.
29. Crombleholme WR, Landers O, Ohm-Smith MJ, Sulbactaml ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections, Drugs 1986; 31 (suppl 2): 11-3.
30. Crombleholme WR, Schachter J, Ohm-Smith MJ, Luft J, Whidden R, Sweet RL, Efficacy ofsingle-agent therapy for the treatment ofacute pelvic inflammatory disease with ciprofloxacin, Am J Med 1989; 87 (suppl 5A): 142-7S.
31. Dodson MG, Faro S, Gentry LO, Treatment ofacute pelvic inflammatory disease with aztreonam, a new monocyclic beta-Iactam antibiotic, and Clindamycin, Obstet Gynecol 1986; 67: 657-62.
32. Faro S, Martens MG, Phillips LE, Lapread E, Riddle GO, Turner RM, Ceftizoxime versus cefotaxime in the treatment of hospitalized patients with pelvic inflammatory disease, CUIT Ther Res 1988; 43: 349-54.
33. Gall SA, Constantine L, Comparative evaluation ofClindamycin versus Clindamycin plus tobramycin in the treatment ofacute pelvic inflammatory disease, Obstet Gynecol 1990; 75: 282-6.
34. Gunning J, A comparison of parenteral sulbactam/ampicillin versus Clindamycin/gentamicin in the treatment of pelvic inflammatory disease, Drugs 1986; 31(suppl 2): 14-7.
35. Hemsell DL, Hemsell PG, Heard MC, Nobles BJ, Piperacillin and a combination of Clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess, Surg Gynecol Obstet 1987; 165: 223-9.
36. Hemsell DL, Heard MC, Hemsell PG, Nobles BJ, Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease, Drugs 1988; 35(suppl 7): 39-42.
37. Hemsell DL, Wendel GO, Gall SA, Multicenter comparison of cefotetan and cefoxitin in the treatment ofacute obstetric and gynecologic infections, Am J Obstet Gynecol 1988; 158: 722-7.
38. Landers DV, Wolner-Hanssen P, Paavonen J, Combination antimicrobial therapy in the treatment ofacute pelvic inflammatory disease, Am J Obstet Gynecol 1991; 164: 849-58.
39. McGreggor JA, Christiansen FB, Treatment of obstetric and gynecologic infections, with an emphasis on beta-lactamase-producing organisms, J Reprod Med 1988; 33(suppl 6): 595-7.
40. Pastorek JG, Cole C, Aldridge KE, Crapanzano JC, Aztreonam plus Clindamycin as therapy for pelvic infections in women, Am J Med 1985; 78(suppl 2A): 47-50.
41. Poindexter AN, Ritter M, Faro S, Results of non-comparative studies of cefotetan in the treatment of obstetric and gynecologic infections, Am J Obstet Gynecol 1988; 158: 717-21.
42. Soper DE, Despres B, A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease, Obstet Gynecol 1988; 72: 7-12.
43. Soper DE, Brockwell NJ, Dalton HP, Microbial etiology ofurban emergency department acute salpingitis: treatment with ofloxacin, Am J Obstet Gynecol 1992; 167: 653-60.
44. Sweet RL, Schachter J, Landers DV, Ohm-Smith MJ, Robbie MO, Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison ofcefotetan plus doxycycline and cefoxitin plus doxycycline, Am J Obstet Gynecol 1988; 158: 736-43.
45. Sweet RL, Landers DV, Schachter J, Crombleholme WR, Sulbactam/ampicillin in the treatment ofacute pelvic inflammatory disease, Int J Gynecol Obstet 1989; (suppl 2): 13-9.
46. Thadepalli H, Mathai O, Scotti R, Bansal MB, Savage E, Ciprofloxacin monotherapy for acute pelvic infections: a comparison with Clindamycin plus gentamicin, Obstet Gynecol 1991; 78: 696.
47. Wolner-Hansen P, Paavonen J, Kiviat N, Ambulatory treatment of suspected pelvic inflammatory disease with augmentin, with or without doxycycline, Am J Obstet Gynecol 1988; 158: 577-9.
48. Brunham RC, Binns B, Guijon F, Etiology and outcome of acute pelvic inflammatory disease, J Infect Dis 1988; 158: 510-7.
49. Obwegeser J, Kunz J, Wust J, Schar G, Steiner R, Buchi W, Clinical efficacy of amoxicillin/c1avulanate in laparoscopically-confirmed salpingitis, J Antimicrob Chemother 1989; 24(suppl B): 165-76.
50. Bruhat MA, Le Bouedec G, Pouly JL, Mage G, Canis M, Treatment of acute salpingitis with sulbactam/ampicillin, Int J Gynaecol Obstet 1989; 2(suppl): 41-6.
51. Heinonen PK, Teisala K, Aine R, Miettinen A, Brief report: intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease, A comparison ofciprofloxacin with doxycycline plus metronidazole, Am J Med 1989; 87(suppl 5A): 152-6S.
52. The European Study Group, Comparative evaluation of Clindamycinl gentamicin and cefoxitin/doxycycline for treatment ofpelvic inflammatory disease: a multi-center trial, Acta Obstet Gynecol Scand 1992; 71: 129-34.
53. Brimer C, Brundin J, Second-look laparoscopy after treatment ofacute salpingitis with doxycycline/belzylpenicillin procaine or trimethoprim-sulfamethoxazole, Scand J Infect Dis Suppl 1988; 53: 65-9.
54. Heinonen PK, Teisala K, Punnonen R, et al, Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole, Genitourin Med 1986; 62: 235-9.
55. Centers for Disease Control and Prevention, 1993 STD treatment guidelines, MMWR 1993 (in press).